Overview Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED) Status: Completed Trial end date: 2009-02-01 Target enrollment: Participant gender: Summary 4-Week Safety Study in Subjects with Neutrophilic Asthma Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.